Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/selegiline-rasagiline-selectivity-lost/
CompareKey points for this combination
MAO-A inhibition becomes relevant when selectivity is lost. This depends on the conditions of selegiline or rasagiline use [26, 34].
General concepts in this text
MAO-A
A form of the MAO enzyme involved in breaking down some chemical messengers, including serotonin.
These messengers are monoamines. MAO-A and MAO-B are two different forms of monoamine oxidase.
Sources: MAO-A
- MedlinePlus Genetics: MAOA gene — Normal Function · Page last updated 2017-05-01; accessed 2026-10-13
- Edmondson, Binda, Mattevi: Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B · Arch Biochem Biophys. 2007;464(2):269–276; DOI 10.1016/j.abb.2007.05.006; PMID 17573034
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
MAO — monoamine oxidase
An enzyme involved in breaking down serotonin.
Breakdown and reuptake are different processes.
Sources: MAO — monoamine oxidase
- OpenStax: Neurotransmitters Made from Amino Acids · Introduction to Behavioral Neuroscience, published 2024-11-13
Serotonin toxicity
A condition caused by excessive serotonin activity in the nervous system.
Also called serotonin syndrome. Features can include tremor and involuntary muscle jerks, raised body temperature, a fast heartbeat, agitation or confusion.
Sources: Serotonin toxicity
- Ables and Nagubilli: Prevention, Diagnosis, and Management of Serotonin Syndrome · American Family Physician 81(9), 1139–1142 (2010)
- Chiew and Isbister: Management of serotonin syndrome (toxicity) · British Journal of Clinical Pharmacology 91(3), 654–661 (2025); first published 26 June 2024; DOI 10.1111/bcp.16152
MAO-B selectivity
Preferential inhibition of the MAO-B form of the enzyme compared with MAO-A.
MAO-A and MAO-B are two forms of monoamine oxidase. Loss of selectivity means more pronounced inhibition of MAO-A.
Sources: MAO-B selectivity
- Merck Manual Professional: Drug–Receptor Interactions — selectivity · Full review June 2025; Abimbola Farinde; peer reviewed by Eva M. Vivian
- EMSAM U.S. prescribing information — MAO isoenzymes and selectivity · U.S. prescribing information revised May 2020; section 12.2
Sources
- [26] RASAGILINE prescribing information · Open publication
- [34] ZELAPAR selegiline prescribing information · Open publication